Actively Recruiting
Long-term Prognosis and Valve Durability of TAVR
Led by Xijing Hospital · Updated on 2024-04-23
1000
Participants Needed
1
Research Sites
778 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.
CONDITIONS
Official Title
Long-term Prognosis and Valve Durability of TAVR
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with severe aortic valve regurgitation or aortic stenosis evaluated by the Heart team and eligible for TAVR therapy
- Patients who understand the purpose of the study, agree to participate, and sign the informed consent form
You will not qualify if you...
- Patients who cannot provide informed consent
- Patients who are participating in other clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xijing Hospital
Xi'an, Shannxi, China, 710032
Actively Recruiting
Research Team
R
Rutao Wang, M.D, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here